Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, Cory Perugino, Vinay S. Mahajan, Jocelyn R. Farmer, Hang Liu, Thomas J. Diefenbach, Alicja Piechocka-Trocha, Kristina Lefteri, Michael T. Waring, Katherine R. Premo, Bruce D. Walker, Jonathan Z. Li, Gaurav Gaiha, Xu G. Yu, Mathias Lichterfeld, Robert F. Padera Jr., Shiv Pillai
doi: https://doi.org/10.1101/2021.03.23.21253885
Naoki Kaneko
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Julie Boucau
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Hsiao-Hsuan Kuo
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Cory Perugino
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
2Division of Rheumatology Allergy and Immunology, Massachusetts General Hospital, Boston, MA 02114
Vinay S. Mahajan
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
3Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115
Jocelyn R. Farmer
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
2Division of Rheumatology Allergy and Immunology, Massachusetts General Hospital, Boston, MA 02114
Hang Liu
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Thomas J. Diefenbach
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Alicja Piechocka-Trocha
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
5Howard Hughes Medical Institute, Chevy Chase MD, 20815
Kristina Lefteri
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Michael T. Waring
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Katherine R. Premo
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Bruce D. Walker
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
5Howard Hughes Medical Institute, Chevy Chase MD, 20815
6Department of Biology and Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139
Jonathan Z. Li
4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115
Gaurav Gaiha
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
7Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114
Xu G. Yu
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Mathias Lichterfeld
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
4Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115
Robert F. Padera Jr.
3Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115
Shiv Pillai
1Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA and Massachusetts Consortium of Pathogen Readiness
Data Availability
There is no genomic or transcriptomic data and there was no clinical trial
Posted March 26, 2021.
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, Cory Perugino, Vinay S. Mahajan, Jocelyn R. Farmer, Hang Liu, Thomas J. Diefenbach, Alicja Piechocka-Trocha, Kristina Lefteri, Michael T. Waring, Katherine R. Premo, Bruce D. Walker, Jonathan Z. Li, Gaurav Gaiha, Xu G. Yu, Mathias Lichterfeld, Robert F. Padera Jr., Shiv Pillai
medRxiv 2021.03.23.21253885; doi: https://doi.org/10.1101/2021.03.23.21253885
Expansion of Cytotoxic CD4+ T cells in the lungs in severe COVID-19
Naoki Kaneko, Julie Boucau, Hsiao-Hsuan Kuo, Cory Perugino, Vinay S. Mahajan, Jocelyn R. Farmer, Hang Liu, Thomas J. Diefenbach, Alicja Piechocka-Trocha, Kristina Lefteri, Michael T. Waring, Katherine R. Premo, Bruce D. Walker, Jonathan Z. Li, Gaurav Gaiha, Xu G. Yu, Mathias Lichterfeld, Robert F. Padera Jr., Shiv Pillai
medRxiv 2021.03.23.21253885; doi: https://doi.org/10.1101/2021.03.23.21253885
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2854)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12563)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4437)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6784)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)